Hironic Co. Ltd
Hironic Co., Ltd. engages in the manufacture and sale of medical and surgical equipment, and other orthopedic appliances in South Korea and internationally. It offers its products for the MFU and RF, laser, plasma, and cryotherapy. The company was founded in 2007 and is headquartered in Yongin-Si, South Korea.
Market Cap & Net Worth: Hironic Co. Ltd (149980)
Hironic Co. Ltd (KQ:149980) has a market capitalization of $53.16 Million (₩77.84 Billion) as of March 19, 2026. Listed on the KQ stock exchange, this Korea-based company holds position #24711 globally and #1457 in its home market, demonstrating a -5.04% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Hironic Co. Ltd's stock price ₩5090.00 by its total outstanding shares 15293400 (15.29 Million).
Hironic Co. Ltd Market Cap History: 2015 to 2025
Hironic Co. Ltd's market capitalization history from 2015 to 2025. Data shows change from $97.45 Million to $53.16 Million (-5.16% CAGR).
Index Memberships
Hironic Co. Ltd is a constituent of 2 market indices:
| Index | Total Market Cap | Weight (%) | Rank by Market Cap |
|---|---|---|---|
|
Kosdaq Composite Index
KOSDAQ
|
$167.61 Billion | 0.01% | #735 of 1384 |
|
Kosdaq Composite Index
KQ11
|
$167.61 Billion | 0.01% | #735 of 1384 |
Weight: Hironic Co. Ltd's market cap as a percentage of total index value. Rank: Position among all constituents by market cap.
Hironic Co. Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Hironic Co. Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
0.00x
Hironic Co. Ltd's market cap is 0.00 times its annual revenue
0.67x
Lower than industry averageLatest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2015 | $97.45 Million | $17.92 Billion | $2.83 Billion | 0.01x | 0.03x |
| 2016 | $57.63 Million | $15.48 Billion | $718.71 Million | 0.00x | 0.08x |
| 2017 | $36.83 Million | $18.13 Billion | $763.25 Million | 0.00x | 0.05x |
| 2018 | $34.51 Million | $20.33 Billion | -$259.88 Million | 0.00x | N/A |
| 2019 | $43.53 Million | $20.13 Billion | $2.90 Billion | 0.00x | 0.01x |
| 2020 | $40.74 Million | $12.99 Billion | $3.18 Billion | 0.00x | 0.01x |
| 2021 | $64.49 Million | $21.78 Billion | $6.78 Billion | 0.00x | 0.01x |
| 2022 | $67.42 Million | $27.57 Billion | $2.93 Billion | 0.00x | 0.02x |
| 2023 | $81.21 Million | $33.73 Billion | $8.22 Billion | 0.00x | 0.01x |
| 2024 | $65.80 Million | $31.63 Billion | -$5.45 Billion | 0.00x | N/A |
Competitor Companies of 149980 by Market Capitalization
Companies near Hironic Co. Ltd in the global market cap rankings as of March 19, 2026.
Key companies related to Hironic Co. Ltd by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #84 globally with a market cap of $187.53 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #151 globally with a market cap of $119.88 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #170 globally with a market cap of $111.60 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #183 globally with a market cap of $105.38 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #84 | Abbott Laboratories | NYSE:ABT | $187.53 Billion | $108.49 |
| #151 | Stryker Corporation | NYSE:SYK | $119.88 Billion | $345.81 |
| #170 | Medtronic PLC | NYSE:MDT | $111.60 Billion | $87.21 |
| #183 | Boston Scientific Corp | NYSE:BSX | $105.38 Billion | $71.28 |
Hironic Co. Ltd Historical Marketcap From 2015 to 2025
Between 2015 and today, Hironic Co. Ltd's market cap moved from $97.45 Million to $ 53.16 Million, with a yearly change of -5.16%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2025 | ₩53.16 Million | -19.21% |
| 2024 | ₩65.80 Million | -18.97% |
| 2023 | ₩81.21 Million | +20.46% |
| 2022 | ₩67.42 Million | +4.54% |
| 2021 | ₩64.49 Million | +58.30% |
| 2020 | ₩40.74 Million | -6.42% |
| 2019 | ₩43.53 Million | +26.15% |
| 2018 | ₩34.51 Million | -6.30% |
| 2017 | ₩36.83 Million | -36.09% |
| 2016 | ₩57.63 Million | -40.86% |
| 2015 | ₩97.45 Million | -- |
End of Day Market Cap According to Different Sources
On Mar 19th, 2026 the market cap of Hironic Co. Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $53.16 Million USD |
| MoneyControl | $53.16 Million USD |
| MarketWatch | $53.16 Million USD |
| marketcap.company | $53.16 Million USD |
| Reuters | $53.16 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.